ScholarIQanswers from OpenAlex

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

PaperCitations, authors & open-access status

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial have?

ScholarIQcitation count

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial has 662 citations in the OpenAlex counts ScholarIQ stores.

When was Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial published?

ScholarIQyear

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial has 2014 year in the ScholarIQ index.

What is the open-access status of Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial?

ScholarIQoa status

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial has hybrid oa status in the ScholarIQ index.

What is the DOI of Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial?

ScholarIQdoi

The DOI for Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial is on the source record.

What is the PMID of Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial?

ScholarIQpmid

The PMID for Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial is on the source record.

What is the OpenAlex record for Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial?

ScholarIQopenalex

The OpenAlex for Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial